A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity

This publication has 10 references indexed in Scilit:

• Presence of a heterozygous substitution and its relationship to DT-diaphorase activity
  British Journal of Cancer, 1995
• Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
  Pharmacogenetics, 1995
• Detection of a Point Mutation in NQ01 (DT-diaphorase) in a Patient With Colon Cancer
  JNCI Journal of the National Cancer Institute, 1995
• An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
  1995
• Expression of NAD(P)H: quinone oxidoreductase and glutathione S-transferases α and π in human renal cell carcinoma and in kidney cancer-derived cell lines
  Carcinogenesis: Integrative Cancer Research, 1994
• Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.
  1994
• Loss of Heterozygosity at the NAD(P)H:Quinone Oxidoreductase Locus Associated with Increased Resistance against Mitomycin C in a Human Bladder Carcinoma Cell Line
  Biological Chemistry Hoppe-Seyler, 1994
• DT-diaphorase in activation and detoxification of quinones
  Cancer and Metastasis Reviews, 1993
• NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
  1992
• METABOLISM OF DIAZIQUONE BY NAD(P)H-(QUINONE ACCEPTOR) OXIDOREDUCTASE (DT-DIAPHORASE) - ROLE IN DIAZIQUONE-INDUCED DNA DAMAGE AND CYTOTOXICITY IN HUMAN COLON-CARCINOMA CELLS
  1990